Lipopolysaccharide distinctively alters human microglia transcriptomes to resemble microglia from Alzheimer's disease mouse models.


Journal

Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332

Informations de publication

Date de publication:
01 10 2022
Historique:
received: 19 10 2021
accepted: 30 08 2022
entrez: 18 10 2022
pubmed: 19 10 2022
medline: 20 10 2022
Statut: ppublish

Résumé

Alzheimer's disease (AD) is the most common form of dementia, and risk-influencing genetics implicates microglia and neuroimmunity in the pathogenesis of AD. Induced pluripotent stem cell (iPSC)-derived microglia (iPSC-microglia) are increasingly used as a model of AD, but the relevance of historical immune stimuli to model AD is unclear. We performed a detailed cross-comparison over time on the effects of combinatory stimulation of iPSC-microglia, and in particular their relevance to AD. We used single-cell RNA sequencing to measure the transcriptional response of iPSC-microglia after 24 h and 48 h of stimulation with prostaglandin E2 (PGE2) or lipopolysaccharide (LPS)+interferon gamma (IFN-γ), either alone or in combination with ATPγS. We observed a shared core transcriptional response of iPSC-microglia to ATPγS and to LPS+IFN-γ, suggestive of a convergent mechanism of action. Across all conditions, we observed a significant overlap, although directional inconsistency to genes that change their expression levels in human microglia from AD patients. Using a data-led approach, we identify a common axis of transcriptomic change across AD genetic mouse models of microglia and show that only LPS provokes a transcriptional response along this axis in mouse microglia and LPS+IFN-γ in human iPSC-microglia. This article has an associated First Person interview with the first author of the paper.

Identifiants

pubmed: 36254682
pii: 277958
doi: 10.1242/dmm.049349
pmc: PMC9612871
pii:
doi:

Substances chimiques

Lipopolysaccharides 0
Interferon-gamma 82115-62-6
Dinoprostone K7Q1JQR04M

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Medical Research Council
ID : MC_EX_MR/N50192X/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0902227
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K013041/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0300429
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/L501517/1
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 100643/Z/12/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17112
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_16034
Pays : United Kingdom

Informations de copyright

© 2022. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests M.Z.C. is co-founder and director of Oxford StemTech Ltd. and HumanCentric DD Ltd. C.W. is co-founder and director of HumanCentric DD Ltd.

Références

Cell. 2015 Mar 12;160(6):1061-71
pubmed: 25728668
Nat Methods. 2017 Sep;14(9):865-868
pubmed: 28759029
Front Neurosci. 2019 Jan 24;13:2
pubmed: 30733664
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Cell Res. 2012 Jun;22(6):1022-33
pubmed: 22231629
Nucleic Acids Res. 2012 Jan;40(Database issue):D857-61
pubmed: 22096227
J Med Chem. 2020 Feb 13;63(3):1032-1050
pubmed: 31904232
Neurochem Res. 2001 Sep;26(8-9):959-69
pubmed: 11699948
Front Immunol. 2020 Aug 26;11:1588
pubmed: 32983082
Stem Cell Reports. 2017 Jun 6;8(6):1727-1742
pubmed: 28591653
Nat Neurosci. 2013 May;16(5):543-51
pubmed: 23525041
Glia. 2007 Apr 15;55(6):604-16
pubmed: 17299767
Nucleic Acids Res. 2019 Jan 8;47(D1):D559-D563
pubmed: 30357367
Neurobiol Aging. 2014 Dec;35(12):2746-2760
pubmed: 25002035
Front Neurol. 2018 Jun 19;9:458
pubmed: 29971040
Cell. 2021 May 27;184(11):3022-3040.e28
pubmed: 33961781
Science. 2011 Sep 9;333(6048):1456-8
pubmed: 21778362
Neurochem Int. 2005 Nov;47(6):442-8
pubmed: 16029911
BMC Genomics. 2019 Feb 28;20(1):164
pubmed: 30819113
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
Immunity. 2019 Jan 15;50(1):253-271.e6
pubmed: 30471926
Sci Rep. 2017 Aug 21;7(1):9003
pubmed: 28827786
Cell Rep. 2019 Apr 23;27(4):1293-1306.e6
pubmed: 31018141
J Neuroinflammation. 2007 Jan 04;4:2
pubmed: 17204153
Toxicol Appl Pharmacol. 2009 Jul 1;238(1):64-70
pubmed: 19397918
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nature. 2019 Jun;570(7761):332-337
pubmed: 31042697
Am J Pathol. 2005 Apr;166(4):1163-72
pubmed: 15793296
Nat Biotechnol. 2016 May;34(5):525-7
pubmed: 27043002
Nucleic Acids Res. 2014 Jan;42(Database issue):D358-63
pubmed: 24234451
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D535-9
pubmed: 16381927
Database (Oxford). 2015 Dec 26;2015:
pubmed: 26708988
Infect Immun. 1999 Jan;67(1):206-12
pubmed: 9864217
Nat Neurosci. 2019 Dec;22(12):2087-2097
pubmed: 31768052
Nat Commun. 2018 Feb 7;9(1):539
pubmed: 29416036
Brain Res. 2012 Mar 9;1442:76-89
pubmed: 22322149
Front Neurosci. 2015 Apr 28;9:148
pubmed: 25972780
J Neurosci. 2014 Apr 23;34(17):5882-94
pubmed: 24760848
Nat Neurosci. 2019 Dec;22(12):2111-2116
pubmed: 31659342
Mol Neurodegener. 2010 Mar 24;5:12
pubmed: 20334662
PLoS Biol. 2014 Jan;12(1):e1001747
pubmed: 24409095
Nat Commun. 2020 Aug 21;11(1):4183
pubmed: 32826893
Glia. 2019 Jul;67(7):1240-1253
pubmed: 30758077
Bioinformatics. 2010 Oct 1;26(19):2363-7
pubmed: 20688976
Cell Rep. 2018 Jan 16;22(3):832-847
pubmed: 29346778
Biochim Biophys Acta. 2015 Apr;1851(4):414-21
pubmed: 25038274
J Neurosci. 1993 Oct;13(10):4403-11
pubmed: 7692013
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9730-4
pubmed: 7692452
Nucleic Acids Res. 2019 Jan 8;47(D1):D1005-D1012
pubmed: 30445434
Prostaglandins Other Lipid Mediat. 2010 Apr;91(3-4):104-12
pubmed: 19808012
J Neurosci. 1999 Jan 15;19(2):520-8
pubmed: 9880572
Nature. 2021 Feb;590(7844):122-128
pubmed: 33473210
Nucleic Acids Res. 2019 Jan 8;47(D1):D607-D613
pubmed: 30476243
Stem Cell Reports. 2017 Feb 14;8(2):334-345
pubmed: 28111278
Bioinformatics. 2012 Mar 15;28(6):799-806
pubmed: 22238271
Stem Cells. 2016 Aug;34(8):2063-78
pubmed: 27097283
Nat Commun. 2020 Aug 7;11(1):3953
pubmed: 32769974
Nat Methods. 2017 Jan;14(1):61-64
pubmed: 27892958
J Neurochem. 1999 Feb;72(2):565-75
pubmed: 9930728
Nat Commun. 2016 Apr 21;7:11295
pubmed: 27097852
Ann Neurol. 2008 Sep;64(3):304-14
pubmed: 18825663
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Nat Neurosci. 2005 Jun;8(6):752-8
pubmed: 15895084
J Neurochem. 2004 Jan;88(1):246-56
pubmed: 14675168
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655
pubmed: 29145629
Pflugers Arch. 2006 Aug;452(5):589-97
pubmed: 16639550
Nature. 2019 Feb;566(7744):388-392
pubmed: 30760929
Exp Mol Med. 2013 Dec 06;45:e66
pubmed: 24310172
J Exp Med. 2018 Mar 5;215(3):745-760
pubmed: 29321225
Cell. 2013 Apr 25;153(3):707-20
pubmed: 23622250
Glia. 2004 Jan 15;45(2):208-12
pubmed: 14730714
Nature. 2020 Oct;586(7829):417-423
pubmed: 32999463

Auteurs

Jimena Monzón-Sandoval (J)

UK Dementia Research Institute, Cardiff University, Cardiff CF24 4HQ, UK.

Elena Burlacu (E)

John Radcliffe Hospital, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DS, UK.

Devika Agarwal (D)

Nuffield Department of Medicine Research Building, Alzheimer's Research UK Oxford Drug Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.
Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.

Adam E Handel (AE)

John Radcliffe Hospital, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DS, UK.

Liting Wei (L)

James Martin Stem Cell Facility, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.

John Davis (J)

Nuffield Department of Medicine Research Building, Alzheimer's Research UK Oxford Drug Discovery Institute, University of Oxford, Oxford OX3 7FZ, UK.

Sally A Cowley (SA)

Translational Molecular Neuroscience Group, New Biochemistry Building, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX1 3QU, UK.

M Zameel Cader (MZ)

John Radcliffe Hospital, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford OX3 9DS, UK.
James Martin Stem Cell Facility, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK.

Caleb Webber (C)

UK Dementia Research Institute, Cardiff University, Cardiff CF24 4HQ, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH